{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:59:52Z","timestamp":1789991992312,"version":"4.0.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.81971543"],"award-info":[{"award-number":["No.81971543"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Four \u201cBatches\u201d Innovation Project of Invigorating Medical through Science and Technology of Shanxi Province","award":["NO.2022XM05"],"award-info":[{"award-number":["NO.2022XM05"]}]},{"name":"The Central Guidance Special Funds for Local Science and Technology Development","award":["YDZJSX20231A061"],"award-info":[{"award-number":["YDZJSX20231A061"]}]},{"name":"Shanxi Province Higher \"Billion Project \" Science Technology Guidance Project","award":["BYJL042"],"award-info":[{"award-number":["BYJL042"]}]},{"name":"Strong Foundation Program and Innovation Project of Invigorating Medical through Science and Technology of Shanxi Province"},{"name":"Sanjin Talent Program\u2013Leading Talents in Healthcare Project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-026-02543-1","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T04:18:24Z","timestamp":1782879504000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Opposing Dynamics of CD4\u2009+\u2009Regulatory and CD8\u2009+\u2009Foxp3+ T Cells Characterize Immune Imbalance in Rheumatoid Arthritis"],"prefix":"10.1007","volume":"49","author":[{"given":"Baochen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanjuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihe","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0817-7946","authenticated-orcid":false,"given":"Caihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"6","key":"2543_CR1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","volume":"79","author":"JS Smolen","year":"2020","unstructured":"Smolen, J.S., R.B.M. Landew\u00e9, J.W.J. Bijlsma, G.R. Burmester, M. Dougados, A. Kerschbaumer, et al. 2020. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of the Rheumatic Diseases 79 (6): 685\u2013699. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216655.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"10","key":"2543_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00018-022-04563-0","volume":"79","author":"S Yan","year":"2022","unstructured":"Yan, S., K. Kotschenreuther, S. Deng, and D.M. Kofler. 2022. Regulatory T cells in rheumatoid arthritis: Functions, development, regulation, and therapeutic potential. Cellular and Molecular Life Sciences 79 (10): 533. https:\/\/doi.org\/10.1007\/s00018-022-04563-0.","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"6","key":"2543_CR3","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.it.2019.04.005","volume":"40","author":"G Christoffersson","year":"2019","unstructured":"Christoffersson, G., and M. von Herrath. 2019. Regulatory immune mechanisms beyond regulatory T cells. Trends in Immunology 40 (6): 482\u2013491. https:\/\/doi.org\/10.1016\/j.it.2019.04.005.","journal-title":"Trends in Immunology"},{"issue":"4","key":"2543_CR4","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.it.2025.02.010","volume":"46","author":"S Luo","year":"2025","unstructured":"Luo, S., J.H. Larson, B.R. Blazar, R. Abdi, and J.S. Bromberg. 2025. Foxp3+ CD8+ regulatory T cells: Bona fide Tregs with cytotoxic function. Trends in Immunology 46 (4): 324\u2013337. https:\/\/doi.org\/10.1016\/j.it.2025.02.010.","journal-title":"Trends in Immunology"},{"issue":"1","key":"2543_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/imr.12812","volume":"292","author":"L Flippe","year":"2019","unstructured":"Flippe, L., S. B\u00e9zie, I. Anegon, and C. Guillonneau. 2019. Future prospects for CD8+ regulatory T cells in immune tolerance. Immunological Reviews 292 (1): 209\u2013224. https:\/\/doi.org\/10.1111\/imr.12812.","journal-title":"Immunological Reviews"},{"issue":"6","key":"2543_CR6","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1172\/JCI71533","volume":"124","author":"E Picarda","year":"2014","unstructured":"Picarda, E., S. B\u00e9zie, V. Venturi, K. Echasserieau, E. M\u00e9rieau, A. Delhumeau, et al. 2014. MHC-derived allopeptide activates TCR-biased CD8+ Tregs and suppresses organ rejection. Journal of Clinical Investigation 124 (6): 2497\u20132512. https:\/\/doi.org\/10.1172\/JCI71533.","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"2543_CR7","first-page":"63","volume":"9","author":"X Long","year":"2017","unstructured":"Long, X., Q. Cheng, H. Liang, J. Zhao, J. Wang, and W. Wang et al. 2017. Memory CD4\u2009+\u2009T cells are suppressed by CD8\u2009+\u2009regulatory T cells in vitro and in vivo. American Journal of Translational Research 9(1):63\u201378.","journal-title":"American Journal of Translational Research"},{"issue":"3","key":"2543_CR8","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/eji.202048614","volume":"51","author":"V Niederlova","year":"2021","unstructured":"Niederlova, V., O. Tsyklauri, T. Chadimova, and O. Stepanek. 2021. CD8+ Tregs revisited: A heterogeneous population with different phenotypes and properties. European Journal of Immunology 51 (3): 512\u2013530. https:\/\/doi.org\/10.1002\/eji.202048614.","journal-title":"European Journal of Immunology"},{"issue":"10","key":"2543_CR9","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1002\/art.38761","volume":"66","author":"SD Ellis","year":"2014","unstructured":"Ellis, S.D., J.L. McGovern, A. van Maurik, D. Howe, M.R. Ehrenstein, and C.A. Notley. 2014. Induced CD8\u2009+\u2009FoxP3+ Treg cells in rheumatoid arthritis are modulated by p38 phosphorylation and monocytes expressing membrane tumor necrosis factor \u03b1 and CD86. Arthritis & Rheumatology 66 (10): 2694\u20132705. https:\/\/doi.org\/10.1002\/art.38761.","journal-title":"Arthritis & Rheumatology"},{"key":"2543_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.imlet.2022.05.004","volume":"247","author":"A Liston","year":"2022","unstructured":"Liston, A., and M. Aloulou. 2022. A fresh look at a neglected regulatory lineage: CD8\u2009+\u2009Foxp3+ regulatory T cells. Immunology Letters 247: 22\u201326. https:\/\/doi.org\/10.1016\/j.imlet.2022.05.004.","journal-title":"Immunology Letters"},{"issue":"6","key":"2543_CR11","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1093\/rheumatology\/keac598","volume":"62","author":"FM Ucci","year":"2023","unstructured":"Ucci, F.M., S. Recalchi, C. Barbati, V. Manganelli, A. Capozzi, G. Riitano, et al. 2023. Citrullinated and carbamylated proteins in extracellular microvesicles from plasma of patients with rheumatoid arthritis. Rheumatology (Oxford, England) 62 (6): 2312\u20132319. https:\/\/doi.org\/10.1093\/rheumatology\/keac598.","journal-title":"Rheumatology (Oxford, England)"},{"key":"2543_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1532114","volume":"16","author":"B Buttari","year":"2025","unstructured":"Buttari, B., S. Recalchi, G. Riitano, A. Capozzi, F.M. Ucci, V. Manganelli, et al. 2025. Extracellular microvesicles from patients with rheumatoid arthritis promote dendritic cell activation in vitro. Frontiers in Immunology 16: 1532114. https:\/\/doi.org\/10.3389\/fimmu.2025.1532114.","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"2543_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.bone.2013.05.024","volume":"56","author":"ZS Buchwald","year":"2013","unstructured":"Buchwald, Z.S., J.R. Kiesel, C. Yang, R. DiPaolo, D.V. Novack, and R. Aurora. 2013. Osteoclast-induced Foxp3\u2009+\u2009CD8 T-cells limit bone loss in mice. Bone 56 (1): 163\u2013173. https:\/\/doi.org\/10.1016\/j.bone.2013.05.024.","journal-title":"Bone"},{"issue":"8","key":"2543_CR14","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1002\/jbmr.2472","volume":"30","author":"ZS Buchwald","year":"2015","unstructured":"Buchwald, Z.S., C. Yang, S. Nellore, E.V. Shashkova, J.L. Davis, A. Cline, et al. 2015. A bone anabolic effect of RANKL in a murine model of osteoporosis mediated through FoxP3\u2009+\u2009CD8 T cells. Journal of Bone and Mineral Research 30 (8): 1508\u20131522. https:\/\/doi.org\/10.1002\/jbmr.2472.","journal-title":"Journal of Bone and Mineral Research"},{"issue":"3","key":"2543_CR15","doi-asserted-by":"publisher","first-page":"726","DOI":"10.4049\/jimmunol.1600253","volume":"197","author":"EV Shashkova","year":"2016","unstructured":"Shashkova, E.V., J. Trivedi, A.B. Cline-Smith, C. Ferris, Z.S. Buchwald, J. Gibbs, et al. 2016. Osteoclast-primed Foxp3\u2009+\u2009CD8 T cells induce T-bet, Eomesodermin, and IFN-\u03b3 to regulate bone resorption. The Journal of Immunology 197 (3): 726\u2013735. https:\/\/doi.org\/10.4049\/jimmunol.1600253.","journal-title":"The Journal of Immunology"},{"issue":"9","key":"2543_CR16","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha, D., T. Neogi, A.J. Silman, J. Funovits, D.T. Felson 3rd., C.O. Bingham, et al. 2010. 2010 rheumatoid arthritis classification criteria: An American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Annals of the Rheumatic Diseases 69 (9): 1580\u20131588. https:\/\/doi.org\/10.1136\/ard.2010.138461.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"10055","key":"2543_CR17","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen, J. S., D. Aletaha, and I. B. McInnes. 2016. Rheumatoid arthritis Lancet 388(10055):2023\u20132038. https:\/\/doi.org\/10.1016\/S0140-6736(16)30173-8","journal-title":"Rheumatoid arthritis Lancet"},{"issue":"10","key":"2543_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cells7100161","volume":"7","author":"HY Yap","year":"2018","unstructured":"Yap, H.Y., S.Z. Tee, M.M. Wong, S.K. Chow, S.C. Peh, and S.Y. Teow. 2018. Pathogenic role of immune cells in rheumatoid arthritis: Implications in clinical treatment and biomarker development. Cells 7 (10): 161. https:\/\/doi.org\/10.3390\/cells7100161.","journal-title":"Cells"},{"issue":"2","key":"2543_CR19","doi-asserted-by":"publisher","first-page":"e1250","DOI":"10.1002\/cti2.1250","volume":"10","author":"Y Yang","year":"2021","unstructured":"Yang, Y., J. Day, F. Souza-Fonseca Guimaraes, I. P. Wicks, and C. Louis. 2021. Natural killer cells in inflammatory autoimmune diseases. Clinical & Translational Immunology 10(2):e1250. https:\/\/doi.org\/10.1002\/cti2.1250","journal-title":"Clinical & Translational Immunology"},{"issue":"29","key":"2543_CR20","doi-asserted-by":"publisher","first-page":"13028","DOI":"10.1073\/pnas.1000546107","volume":"107","author":"K S\u00f6derstr\u00f6m","year":"2010","unstructured":"S\u00f6derstr\u00f6m, K., E. Stein, P. Colmenero, U. Purath, U. M\u00fcller-Ladner, C.T. de Matos, et al. 2010. Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis. Proceedings of the National Academy of Sciences of the United States of America 107 (29): 13028\u201313033. https:\/\/doi.org\/10.1073\/pnas.1000546107.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"2543_CR21","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1365-2567.2007.02638.x","volume":"122","author":"CT de Matos","year":"2007","unstructured":"de Matos, C.T., L. Berg, J. Micha\u00eblsson, L. Fell\u00e4nder-Tsai, K. K\u00e4rre, and K. S\u00f6derstr\u00f6m. 2007. Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: Role of CD94\/NKG2A in control of cytokine secretion. Immunology 122 (2): 291\u2013301. https:\/\/doi.org\/10.1111\/j.1365-2567.2007.02638.x.","journal-title":"Immunology"},{"issue":"5","key":"2543_CR22","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3390\/genes11050492","volume":"11","author":"NM Elemam","year":"2020","unstructured":"Elemam, N.M., M.Y. Hachim, S. Hannawi, and A.A. Maghazachi. 2020. Differentially expressed genes of natural killer cells can distinguish rheumatoid arthritis patients from healthy controls. Genes 11 (5): 492. https:\/\/doi.org\/10.3390\/genes11050492.","journal-title":"Genes"},{"issue":"1","key":"2543_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/03009742.2019.1634755","volume":"49","author":"EC Schwaneck","year":"2020","unstructured":"Schwaneck, E.C., R. Renner, L. Junker, H.P. Tony, S. Kleinert, M. Gernert, et al. 2020. T cells, natural killer cells, and \u03b3\u03b4T cells in a large patient cohort with rheumatoid arthritis: Influence of age and anti-rheumatic therapy. Scandinavian Journal of Rheumatology 49 (1): 8\u201312. https:\/\/doi.org\/10.1080\/03009742.2019.1634755.","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"1","key":"2543_CR24","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1038\/s41598-020-62654-z","volume":"10","author":"SJ Lin","year":"2020","unstructured":"Lin, S.J., C.Y. Hsu, M.L. Kuo, P.T. Lee, H.S. Hsiao, and J.Y. Chen. 2020. Phenotypic and functional characterization of natural killer cells in rheumatoid arthritis-regulation with interleukin-15. Scientific Reports 10 (1): 5858. https:\/\/doi.org\/10.1038\/s41598-020-62654-z.","journal-title":"Scientific Reports"},{"issue":"7","key":"2543_CR25","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1302\/2046-3758.117.BJR-2021-0594.R1","volume":"11","author":"P Luo","year":"2022","unstructured":"Luo, P., P. Wang, J. Xu, W. Hou, P. Xu, K. Xu, et al. 2022. Immunomodulatory role of T helper cells in rheumatoid arthritis. Bone & Joint Research 11 (7): 426\u2013438. https:\/\/doi.org\/10.1302\/2046-3758.117.BJR-2021-0594.R1.","journal-title":"Bone & Joint Research"},{"issue":"1","key":"2543_CR26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s13075-020-02349-y","volume":"22","author":"J Aldridge","year":"2020","unstructured":"Aldridge, J., A.H. Ekwall, L. Mark, B. Bergstr\u00f6m, K. Andersson, I. Gjertsson, et al. 2020. T helper cells in synovial fluid of patients with rheumatoid arthritis primarily have a Th1 and a CXCR3\u2009+\u2009Th2 phenotype. Arthritis Research & Therapy 22 (1): 245. https:\/\/doi.org\/10.1186\/s13075-020-02349-y.","journal-title":"Arthritis Research & Therapy"},{"issue":"3","key":"2543_CR27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/1756-185X.12132","volume":"16","author":"G Azizi","year":"2013","unstructured":"Azizi, G., F. Jadidi-Niaragh, and A. Mirshafiey. 2013. Th17 cells in immunopathogenesis and treatment of rheumatoid arthritis. International Journal of Rheumatic Diseases 16 (3): 243\u2013253. https:\/\/doi.org\/10.1111\/1756-185X.12132.","journal-title":"International Journal of Rheumatic Diseases"},{"issue":"1","key":"2543_CR28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/art.25058","volume":"62","author":"CA Notley","year":"2010","unstructured":"Notley, C.A., F.E. McCann, J.J. Inglis, and R.O. Williams. 2010. ANTI-CD3 therapy expands the numbers of CD4\u2009+\u2009and CD8\u2009+\u2009Treg cells and induces sustained amelioration of collagen-induced arthritis. Arthritis and Rheumatism 62 (1): 171\u2013178. https:\/\/doi.org\/10.1002\/art.25058.","journal-title":"Arthritis and Rheumatism"},{"key":"2543_CR29","doi-asserted-by":"crossref","unstructured":"Sun, J., Y. Yang, X. Huo, B. Zhu, Z. Li, and X. Jiang et al. 2019. Efficient Therapeutic Function and Mechanisms of Human Polyclonal CD8\u2009+\u2009CD103+Foxp3\u2009+\u2009Regulatory T Cells on Collagen-Induced Arthritis in Mice. Journal of Immunology Research: 8575407.","DOI":"10.1155\/2019\/8575407"},{"key":"2543_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.626193","volume":"12","author":"Q Jiang","year":"2021","unstructured":"Jiang, Q., G. Yang, Q. Liu, S. Wang, and D. Cui. 2021. Function and role of regulatory T cells in rheumatoid arthritis. Frontiers in Immunology 12: 626193. https:\/\/doi.org\/10.3389\/fimmu.2021.626193.","journal-title":"Frontiers in Immunology"},{"issue":"12","key":"2543_CR31","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.3899\/jrheum.110283","volume":"38","author":"SY Kawashiri","year":"2011","unstructured":"Kawashiri, S.Y., A. Kawakami, A. Okada, T. Koga, M. Tamai, S. Yamasaki, et al. 2011. CD4\u2009+\u2009CD25(high)CD127(low\/-) Treg cell frequency from peripheral blood correlates with disease activity in patients with rheumatoid arthritis. The Journal of Rheumatology 38 (12): 2517\u20132521. https:\/\/doi.org\/10.3899\/jrheum.110283.","journal-title":"The Journal of Rheumatology"},{"issue":"7","key":"2543_CR32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41584-022-00793-5","volume":"18","author":"N Komatsu","year":"2022","unstructured":"Komatsu, N., and H. Takayanagi. 2022. Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions. Nature Reviews Rheumatology 18 (7): 415\u2013429. https:\/\/doi.org\/10.1038\/s41584-022-00793-5.","journal-title":"Nature Reviews Rheumatology"},{"key":"2543_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.867260","volume":"13","author":"M Cutolo","year":"2022","unstructured":"Cutolo, M., R. Campitiello, E. Gotelli, and S. Soldano. 2022. The role of M1\/M2 macrophage polarization in rheumatoid arthritis synovitis. Frontiers in Immunology 13: 867260. https:\/\/doi.org\/10.3389\/fimmu.2022.867260.","journal-title":"Frontiers in Immunology"},{"key":"2543_CR34","doi-asserted-by":"publisher","first-page":"108793","DOI":"10.1016\/j.clim.2021.108793","volume":"230","author":"S Liu","year":"2021","unstructured":"Liu, S., H. Ma, H. Zhang, C. Deng, and P. Xin. 2021. Recent advances on signaling pathways and their inhibitors in rheumatoid arthritis. Clinical Immunology 230:108793. https:\/\/doi.org\/10.1016\/j.clim.2021.108793","journal-title":"Clinical Immunology"},{"issue":"20","key":"2543_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222010922","volume":"22","author":"N Kondo","year":"2021","unstructured":"Kondo, N., T. Kuroda, and D. Kobayashi. 2021. Cytokine networks in the pathogenesis of rheumatoid arthritis. International Journal of Molecular Sciences 22 (20): 10922. https:\/\/doi.org\/10.3390\/ijms222010922.","journal-title":"International Journal of Molecular Sciences"},{"key":"2543_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108858","volume":"108","author":"F Rezaei Kahmini","year":"2022","unstructured":"Rezaei Kahmini, F., S. Shahgaldi, M. Azimi, and A.H. Mansourabadi. 2022. Emerging therapeutic potential of regulatory T (Treg) cells for rheumatoid arthritis: New insights and challenge. International Immunopharmacology 108: 108858. https:\/\/doi.org\/10.1016\/j.intimp.2022.108858.","journal-title":"International Immunopharmacology"},{"issue":"10086","key":"2543_CR37","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","volume":"389","author":"IB McInnes","year":"2017","unstructured":"McInnes, I.B., and G. Schett. 2017. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet 389 (10086): 2328\u20132337. https:\/\/doi.org\/10.1016\/S0140-6736(17)31472-1.","journal-title":"Lancet"},{"issue":"1","key":"2543_CR38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","volume":"12","author":"GD Kalliolias","year":"2016","unstructured":"Kalliolias, G.D., and L.B. Ivashkiv. 2016. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nature Reviews Rheumatology 12 (1): 49\u201362. https:\/\/doi.org\/10.1038\/nrrheum.2015.169.","journal-title":"Nature Reviews Rheumatology"},{"issue":"1","key":"2543_CR39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nrrheum.2015.171","volume":"12","author":"IB McInnes","year":"2016","unstructured":"McInnes, I.B., C.D. Buckley, and J.D. Isaacs. 2016. Cytokines in rheumatoid arthritis - shaping the immunological landscape. Nature Reviews Rheumatology 12 (1): 63\u201368. https:\/\/doi.org\/10.1038\/nrrheum.2015.171.","journal-title":"Nature Reviews Rheumatology"},{"issue":"1","key":"2543_CR40","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a031245","volume":"9","author":"K Okamoto","year":"2019","unstructured":"Okamoto, K., and H. Takayanagi. 2019. Osteoimmunology. Cold Spring Harbor Perspectives in Medicine 9 (1): a031245. https:\/\/doi.org\/10.1101\/cshperspect.a031245.","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"11","key":"2543_CR41","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1084\/jem.20072707","volume":"205","author":"CA Notley","year":"2008","unstructured":"Notley, C.A., J.J. Inglis, S. Alzabin, F.E. McCann, K.E. McNamee, and R.O. Williams. 2008. Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells. Journal of Experimental Medicine 205 (11): 2491\u20132497. https:\/\/doi.org\/10.1084\/jem.20072707.","journal-title":"Journal of Experimental Medicine"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-026-02543-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02543-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02543-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:02:39Z","timestamp":1789988559000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-026-02543-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2543"],"URL":"https:\/\/doi.org\/10.1007\/s10753-026-02543-1","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Second Hospital of Shanxi Medical University [Approval (2019) YX No. (105)].","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"187"}}